FI771976A - - Google Patents

Info

Publication number
FI771976A
FI771976A FI771976A FI771976A FI771976A FI 771976 A FI771976 A FI 771976A FI 771976 A FI771976 A FI 771976A FI 771976 A FI771976 A FI 771976A FI 771976 A FI771976 A FI 771976A
Authority
FI
Finland
Application number
FI771976A
Inventor
Richard Everett Philion
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of FI771976A publication Critical patent/FI771976A/fi
Priority to FI830796A priority Critical patent/FI830796L/fi
Priority to FI830797A priority patent/FI830797L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI771976A 1976-06-25 1977-06-23 FI771976A (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI830796A FI830796L (fi) 1976-06-25 1983-03-09 Foerfarande foer framstaellning av 4-hydroxifenyletylaminderivat
FI830797A FI830797L (fi) 1976-06-25 1983-03-09 4-hydroxifenylalkanolamin-derivat och deras framstaellning

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
US80337277A 1977-06-03 1977-06-03

Publications (1)

Publication Number Publication Date
FI771976A true FI771976A (fi) 1977-12-26

Family

ID=27106508

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771976A FI771976A (fi) 1976-06-25 1977-06-23

Country Status (21)

Country Link
JP (1) JPS5321134A (fi)
AR (2) AR220896A1 (fi)
AT (1) AT354420B (fi)
AU (1) AU512626B2 (fi)
CA (1) CA1091245A (fi)
CH (2) CH627447A5 (fi)
DE (1) DE2728641A1 (fi)
DK (1) DK146386C (fi)
ES (1) ES460040A1 (fi)
FI (1) FI771976A (fi)
FR (1) FR2366272A1 (fi)
GB (1) GB1544872A (fi)
HK (1) HK60184A (fi)
IE (1) IE45631B1 (fi)
IL (1) IL52353A (fi)
LU (1) LU77604A1 (fi)
NL (1) NL7707128A (fi)
NO (1) NO144848C (fi)
PH (2) PH15041A (fi)
PT (1) PT66713B (fi)
SE (1) SE7707341L (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
FR2623804B1 (fr) * 1987-11-27 1990-03-23 Elf Aquitaine Acylation des phenols
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
ES2146709T3 (es) 1991-08-21 2000-08-16 Smith & Nephew Inc Sistema de control de fluidos.
WO1999037294A2 (en) 1998-01-26 1999-07-29 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
DE60008697T2 (de) * 2000-03-28 2005-02-10 Council Of Scientific And Industrial Research Verfahren zur Herstellung von 4-(P-methoxyphenyl)-2-amino-butane und Insektizide
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
TWI545109B (zh) * 2009-05-19 2016-08-11 本州化學工業有限公司 4-醯基芳烷基苯酚及其衍生物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (zh) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 一种倒立式拉丝机的卸线车
HU231124B1 (hu) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Eljárás morfológiailag egységes mirabegron és mirabegron monohidroklorid előállítására
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
PH15041A (en) 1982-05-20
AT354420B (de) 1979-01-10
DE2728641A1 (de) 1978-01-05
LU77604A1 (fi) 1978-02-01
AR220896A1 (es) 1980-12-15
PT66713A (en) 1977-07-01
AU512626B2 (en) 1980-10-23
JPS5321134A (en) 1978-02-27
DK146386B (da) 1983-09-26
IE45631B1 (en) 1982-10-20
PH14332A (en) 1981-05-29
NL7707128A (nl) 1977-12-28
FR2366272A1 (fr) 1978-04-28
NO144848C (no) 1981-11-25
PT66713B (en) 1978-11-21
DK281777A (da) 1977-12-26
NO144848B (no) 1981-08-17
IL52353A0 (en) 1977-08-31
CA1091245A (en) 1980-12-09
AR227126A1 (es) 1982-09-30
DK146386C (da) 1984-03-12
AU2636877A (en) 1979-01-04
ATA449377A (de) 1979-06-15
CH630068A5 (en) 1982-05-28
IL52353A (en) 1981-07-31
IE45631L (en) 1977-12-25
FR2366272B1 (fi) 1981-03-06
ES460040A1 (es) 1978-05-01
SE7707341L (sv) 1978-02-13
CH627447A5 (en) 1982-01-15
NO772245L (no) 1977-12-28
HK60184A (en) 1984-08-10
GB1544872A (en) 1979-04-25

Similar Documents

Publication Publication Date Title
FR2366272B1 (fi)
JPS5622442B2 (fi)
JPS5630690B2 (fi)
FR2320729B3 (fi)
FR2353948B1 (fi)
JPS5641310Y2 (fi)
FR2363933B1 (fi)
JPS52129806U (fi)
JPS564834Y2 (fi)
JPS52134736U (fi)
JPS5347069U (fi)
JPS52127843U (fi)
JPS52170178U (fi)
JPS537136U (fi)
JPS5345513U (fi)
JPS5367434U (fi)
JPS5366245U (fi)
BG23353A1 (fi)
CH601667A5 (fi)
CH342276A4 (fi)
DD125647A1 (fi)
BG23357A1 (fi)
BG23354A1 (fi)
CH611438A5 (fi)
BE851241A (fi)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: STERLING DRUG, INC.